If they keep growing like they did in the past, they should trade a lot higher in a year from now:
Revenues[USD]...Earnings[USD].EPS[USD]..Shares.....Equity[USD]
2004:..4423000....502000.......0.01.....36273000..(367000)
2005:..5466000...(1211000)....(0.03)....41617000..2851000
2006:..7745000....534000.......0.01.....53098000..3946000
2007:..8128000....340000.......0.00.....73196000..5786000
2008:.11986000...1564000.......0.02.....75340000..8255000
First 6 months of 2009:
Revenues[USD]...Earnings[USD].EPS[USD]..Shares....Equity
2009:..6375000...1497000.......0.02.....77955000..8952000
Also an interesting observation is, that their operating costs went down from average of 2.9 mio USD (for previous 3 quarters (q3.08, q4.09, q1.09) to only 1.5 mio USD in the last quarter. If they can keep costs down and increase revenues they will increase their EPS nicely (last quarter had an EPS of 1.5 cents).
With growing living standards in China and increasing awareness regarding infectious diseases such as swine flu or bird flu, I believe they will keep growing much more and faster in the years to come. It is difficult to see how they could manage not to grow. As long as demand increases, so should their revenues.
They claim to have 56 different products including disinfectants in liquid, tablet, powder and aerosol forms. They claims to have approximately 6,000 active and recurring customers including hospitals, medical suppliers, and distribution companies throughout China, and to have over 20 distribution contracts with wholesale dealers and agents.
